Is Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) a Buy, Sell, or Hold?
NASDAQ : LABT
Lakewood-Amedex Biotherapeutics Inc. Common Stock — Financials
$1.92 USD
-$0.01 (-0.52%)
- Volume
- 44.49K
- Average Volume
- 298.86K
- Market Capitalization
- $900.32K
- P/E Ratio
- Dividend Yield
- %
- Price Target
- Year High
- $9.26
- Year Low
- $0.37
- Day High
- —
- Day Low
- —
- Payout Ratio
- Current Ratio
LABT Financial Statements
| date | 2026-03-31 |
|---|---|
| revenue | - |
| costOfRevenue | - |
| grossProfit | - |
| researchAndDevelopmentExpenses | 182.15K |
| generalAndAdministrativeExpenses | 703.44K |
| sellingAndMarketingExpenses | - |
| sellingGeneralAndAdministrativeExpenses | 703.44K |
| otherExpenses | 1159 |
| operatingExpenses | 886.75K |
| costAndExpenses | 886.75K |
| netInterestIncome | -37141 |
| interestIncome | 1078 |
| interestExpense | 38219 |
| depreciationAndAmortization | 1159 |
| ebitda | -886.19K |
| ebit | -887.35K |
| nonOperatingIncomeExcludingInterest | 600 |
| operatingIncome | -886.75K |
| totalOtherIncomeExpensesNet | -36541 |
| incomeBeforeTax | -923.29K |
| incomeTaxExpense | - |
| netIncomeFromContinuingOperations | -923.29K |
| netIncomeFromDiscontinuedOperations | - |
| otherAdjustmentsToNetIncome | - |
| netIncome | -923.29K |
| netIncomeDeductions | 493.19K |
| bottomLineNetIncome | -1.42M |
| eps | -2 |
| date | 2026-03-31 |
|---|---|
| cashAndCashEquivalents | 11709 |
| shortTermInvestments | - |
| cashAndShortTermInvestments | 11709 |
| netReceivables | - |
| accountsReceivables | - |
| otherReceivables | - |
| inventory | - |
| prepaids | 38917 |
| otherCurrentAssets | - |
| totalCurrentAssets | 50626 |
| propertyPlantEquipmentNet | 8066 |
| goodwill | - |
| intangibleAssets | - |
| goodwillAndIntangibleAssets | - |
| longTermInvestments | - |
| taxAssets | - |
| otherNonCurrentAssets | 137.65K |
| totalNonCurrentAssets | 145.72K |
| otherAssets | - |
| totalAssets | 196.34K |
| totalPayables | 547.83K |
| accountPayables | 547.83K |
| otherPayables | - |
| accruedExpenses | 733.82K |
| shortTermDebt | 1.62M |
| capitalLeaseObligationsCurrent | 121.04K |
| taxPayables | - |
| deferredRevenue | - |
| otherCurrentLiabilities | - |
| totalCurrentLiabilities | 3.03M |
| longTermDebt | - |
| capitalLeaseObligationsNonCurrent | 10295 |
| deferredRevenueNonCurrent | - |
| deferredTaxLiabilitiesNonCurrent | - |
| otherNonCurrentLiabilities | - |
| totalNonCurrentLiabilities | 10295 |
| otherLiabilities | - |
| capitalLeaseObligations | 131.34K |
| totalLiabilities | 3.04M |
| treasuryStock | -150K |
| preferredStock | 3040 |
| commonStock | 704 |
| retainedEarnings | -54.27M |
| additionalPaidInCapital | 51.58M |
| date | 2026-03-31 |
|---|---|
| netIncome | -923.29K |
| depreciationAndAmortization | 30492 |
| deferredIncomeTax | - |
| stockBasedCompensation | 46180 |
| changeInWorkingCapital | 496.93K |
| accountsReceivables | - |
| inventory | - |
| accountsPayables | 166.79K |
| otherWorkingCapital | 330.14K |
| otherNonCashItems | - |
| netCashProvidedByOperatingActivities | -349.69K |
| investmentsInPropertyPlantAndEquipment | - |
| acquisitionsNet | - |
| purchasesOfInvestments | - |
| salesMaturitiesOfInvestments | - |
| otherInvestingActivities | - |
| netCashProvidedByInvestingActivities | - |
| netDebtIssuance | 125K |
| longTermNetDebtIssuance | - |
| shortTermNetDebtIssuance | 125K |
| netStockIssuance | - |
| netCommonStockIssuance | - |
| commonStockIssuance | - |
| commonStockRepurchased | - |
| netPreferredStockIssuance | - |
| netDividendsPaid | - |
| commonDividendsPaid | - |
| preferredDividendsPaid | - |
| otherFinancingActivities | - |
| netCashProvidedByFinancingActivities | 125K |